Pain Therapeutics, Inc. (PTIE) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Pain Therapeutics, Inc. (PTIE)

An SI Board Since January 2006

Posts	SubjectMarks	Bans	Symbol
28	6	0	PTIE

Emcee: Jack@SI	Type: Unmoderated

Introduction Market Data Compact

Recently PTIE closed a deal with King Pharmaceuticals on its abuse resistent opioid pain killer, Remoxy, and on 1/4/06 was paid $150 M. The deal could bring as much as $400 M plus royalties. PTIE also has Oxytrex, an opioid pain killer that has fewer side effects and fewer withdrawal complications than other opioid pain killers. A recent Oxytrex P III trial was under powered for the desired indication and PTIE must now design a new P III which should get this drug approved. Plenty of money and good prospects.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
28	<i>>Interesting price today - but maybe I am missing something? Yesterd	DewDiligence_on_SI	-	12/18/2010
27	<i>Very odd</i> Yes and it continues with a million plus share day F	Steve Lokness	-	12/5/2010
26	very odd.	mopgcw	-	12/2/2010
25	<i>certainly a cash pile </i> Interesting price today - but maybe I	Steve Lokness	-	12/2/2010
24	<i>if there is a large holder etc.</i> Interesting that after getti	Steve Lokness	-	10/28/2010
23	certainly a cash pile + a drug future is very tempting in the takeover world and	mopgcw	-	10/28/2010
22	<i>Wild to see a biotech do this. Bravo.</i> I'm wondering if s	Steve Lokness	-	10/27/2010
21	Wild to see a biotech do this. Bravo.	mopgcw	-	10/27/2010
20	PTIE - Too much money? Give it to shareholders; <i>Pain Therapeutics Decl	Steve Lokness	-	10/27/2010
19	CS: Pain Therapeutics. Inc. (PTIE) NEUTRAL [V] S. Hirsch CP: US$ 4.47 TP: US$ 5	mopgcw	-	4/22/2009
18	FDA Asks if Pain Pill Is Tamper-Proof By JENNIFER CORBETT DOOREN - NOVEMBER 11,	tnsaf	-	11/11/2008
17	And now Purdue's new version of Oxycontin is in front of the FDA, and thus a	tuck	-	3/27/2008
16	Alpharma Submits NDA for Embeda: siliconinvestor.com	DewDiligence_on_SI	-	2/28/2008
15	>>Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy	tuck	-	12/6/2007
14	Does anyone know of when these products will be available ?	longtermholdings	-	12/8/2006
13	Is it possible to get on a list for potential test patients for this and other p	longtermholdings	-	12/6/2006
12	Pain Therapeutics Announces Positive Phase I Study Results With PTI-202 Nov 29	LJM	-	11/29/2006
11	Another pain drug from the PTIE/King alliance. SOUTH SAN FRANCISCO, Calif. and	Jack@SI	-	8/2/2006
10	Pain Therapeutics' First Quarter 2006 Financial Results Reflect Operating an	Jack@SI	-	5/4/2006
9	Jim Cramer likes PTIE Message 22188721	Doc Bones	-	2/21/2006
8	Pain Therapeutics and King Pharmaceuticals Receive Special Protocol Assessment f	Jack@SI	-	2/16/2006
7	The CEO did well putting together the King deal the particulars now well known.	Jack@SI	-	2/10/2006
6	One thing I can add is the ptie ceo is one of the least impressive bio ceos I	rkrw	-	2/9/2006
5	>>"Sometimes even Cramer can make mistakes," Jim Cramer told vie	tuck	-	2/9/2006
4	"Cramer effect on PTIE." "Sometimes even Cramer can make mistake	LJM	-	2/9/2006

Go to reply# or date (mm/dd/yy):